Long-term HPV type-specific risks for ASCUS and LSIL: A 14-year follow-up of a randomized primary HPV screening trial

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial

(2014) K. M. Elfstrom et al.   BMJ-British Medical Journal

Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer

(2012) Peng Guan et al.   INTERNATIONAL JOURNAL OF CANCER

The 2010 Global Proficiency Study of Human Papillomavirus Genotyping in Vaccinology

(2012) C. Eklund et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Cytology and Human Papillomavirus Testing 6 to 12 Months after ASCUS or LSIL Cytology in Organized Screening To Predict High-Grade Cervical Neoplasia between Screening Rounds

(2012) Ameli Tropé et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Modeling Preventative Strategies against Human Papillomavirus-Related Disease in Developed Countries

(2012) Karen Canfell et al.   VACCINE

Global Proficiency Study of Human Papillomavirus Genotyping

(2010) C. Eklund et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions

(2009) S Brismar-Wendel et al.   BRITISH JOURNAL OF CANCER

Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants

(2009) Nicolas Wentzensen et al.   INTERNATIONAL JOURNAL OF CANCER

Modified General Primer PCR System for Sensitive Detection of Multiple Types of Oncogenic Human Papillomavirus

(2009) A. Soderlund-Strand et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A Systematic Review of the Prevalence and Attribution of Human Papillomavirus Types among Cervical, Vaginal, and Vulvar Precancers and Cancers in the United States

(2008) R. P. Insinga et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION